Ultralife Corp reports results for the quarter ended December 31 - Earnings Summary

• Ultralife Corp ULBI.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 18 cents. The lone analyst forecast for the quarter was for earnings of 15 cents per share.

• Revenue fell 1.6% to $43.85 million from a year ago; analysts expected $40.00 million.

• Ultralife Corp's reported EPS for the quarter was 1 cent​.

• The company reported quarterly net income of $194 thousand.

• Ultralife Corp shares had held steady so far this quarter and lost 27.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the electrical components & equipment peer group is also "buy"

• Wall Street's median 12-month price target for Ultralife Corp is $14.00

This summary was machine generated from LSEG data April 1 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)